These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 39079559)

  • 1. Care Patterns and Barriers to Outpatient Care for Adults With AML Following Intensive Chemotherapy at NCCN Member Institutions.
    Halpern AB; Sugalski JM; Bandini L; Othus M; Stewart FM; Walter RB
    J Natl Compr Canc Netw; 2024 Jul; 22(7):469-474. PubMed ID: 39079559
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Financial Implications of Early Hospital Discharge After AML-Like Induction Chemotherapy: A 4-Year Retrospective Analysis.
    Moore NJ; Othus M; Halpern AB; Howard NP; Tang L; Bastys KE; Percival MM; Hendrie PC; Hartley GA; Welch VL; Estey EH; Walter RB
    J Natl Compr Canc Netw; 2021 Jun; ():1-10. PubMed ID: 34161925
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Resource Utilization and Safety of Outpatient Management Following Intensive Induction or Salvage Chemotherapy for Acute Myeloid Leukemia or Myelodysplastic Syndrome: A Nonrandomized Clinical Comparative Analysis.
    Vaughn JE; Othus M; Powell MA; Gardner KM; Rizzuto DL; Hendrie PC; Becker PS; Pottinger PS; Estey EH; Walter RB
    JAMA Oncol; 2015 Nov; 1(8):1120-7. PubMed ID: 26355382
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative analysis of infectious complications with outpatient
    Halpern AB; Othus M; Howard NP; Hendrie PC; Percival MM; Hartley GA; Welch VL; Estey EH; Walter RB
    Leuk Lymphoma; 2022 Jan; 63(1):142-151. PubMed ID: 34608844
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Outpatient care of patients with acute myeloid leukemia: Benefits, barriers, and future considerations.
    Vaughn JE; Buckley SA; Walter RB
    Leuk Res; 2016 Jun; 45():53-8. PubMed ID: 27101148
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Comparison of Inpatient and Outpatient-Based Chemotherapy Regimens for the Treatment of Acute Myeloid Leukaemia In The Elderly.
    Daly AB; Cuthbert R; Finnegan D; Arnold C; Craddock C; McMullin MF
    Ulster Med J; 2019 Jan; 88(1):25-29. PubMed ID: 30675075
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comparison of resource utilization following chemotherapy for acute myeloid leukemia in children discharged versus children that remain hospitalized during neutropenia.
    Getz KD; Miller TP; Seif AE; Li Y; Huang YS; Bagatell R; Fisher BT; Aplenc R
    Cancer Med; 2015 Sep; 4(9):1356-64. PubMed ID: 26105201
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Outpatient induction and consolidation care strategies in acute myeloid leukemia.
    Halpern AB; Walter RB; Estey EH
    Curr Opin Hematol; 2019 Mar; 26(2):65-70. PubMed ID: 30585894
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Outpatient management following intensive induction or salvage chemotherapy for acute myeloid leukemia.
    Walter RB; Taylor LR; Gardner KM; Dorcy KS; Vaughn JE; Estey EH
    Clin Adv Hematol Oncol; 2013; 11(9):571-7. PubMed ID: 24518520
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Medical Outcomes, Quality of Life, and Family Perceptions for Outpatient vs Inpatient Neutropenia Management After Chemotherapy for Pediatric Acute Myeloid Leukemia.
    Getz KD; Szymczak JE; Li Y; Madding R; Huang YV; Aftandilian C; Arnold SD; Bona KO; Caywood E; Collier AB; Gramatges MM; Henry M; Lotterman C; Maloney K; Mian A; Mody R; Morgan E; Raetz EA; Rubnitz J; Verma A; Winick N; Wilkes JJ; Yu JC; Fisher BT; Aplenc R
    JAMA Netw Open; 2021 Oct; 4(10):e2128385. PubMed ID: 34709389
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Postremission treatment of elderly patients with acute myeloid leukemia in first complete remission after intensive induction chemotherapy: results of the multicenter randomized Acute Leukemia French Association (ALFA) 9803 trial.
    Gardin C; Turlure P; Fagot T; Thomas X; Terre C; Contentin N; Raffoux E; de Botton S; Pautas C; Reman O; Bourhis JH; Fenaux P; Castaigne S; Michallet M; Preudhomme C; de Revel T; Bordessoule D; Dombret H
    Blood; 2007 Jun; 109(12):5129-35. PubMed ID: 17341661
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment patterns, healthcare resource utilization, and costs in patients with acute myeloid leukemia in commercially insured and Medicare populations.
    Stein EM; Bonifacio G; Latremouille-Viau D; Guerin A; Shi S; Gagnon-Sanschagrin P; Briggs O; Joseph GJ
    J Med Econ; 2018 Jun; 21(6):556-563. PubMed ID: 29304724
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Economic and Clinical Burden of Acute Myeloid Leukemia Episodes of Care in the United States: A Retrospective Analysis of a Commercial Payer Database.
    Pandya BJ; Chen CC; Medeiros BC; McGuiness CB; Wilson SD; Walsh EH; Wade RL
    J Manag Care Spec Pharm; 2020 Jul; 26(7):849-859. PubMed ID: 32281456
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of early discharge after hospital treatment of neutropenic fever in acute myeloid leukemia (AML).
    Chow V; Dorcy KS; Sandhu R; Gardner K; Becker P; Pagel J; Hendrie P; Abkowitz J; Appelbaum F; Estey E
    Leuk Res Rep; 2013; 2(1):26-8. PubMed ID: 24371771
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An Evaluation of Treatment Patterns and Outcomes in Elderly Patients Newly Diagnosed With Acute Myeloid Leukemia: A Retrospective Analysis of Electronic Medical Records From US Community Oncology Practices.
    Ma E; Bonthapally V; Chawla A; Lefebvre P; Swords R; Lafeuille MH; Fortier J; Emond B; Duh MS; Dezube BJ
    Clin Lymphoma Myeloma Leuk; 2016 Nov; 16(11):625-636.e3. PubMed ID: 27686689
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Health economic impact of high-dose versus standard-dose cytarabine induction chemotherapy for acute myeloid leukaemia.
    Fedele PL; Avery S; Patil S; Spencer A; Haas M; Wei A
    Intern Med J; 2014 Aug; 44(8):757-63. PubMed ID: 24863325
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regimen-intensity per count-recovery and hospitalization index: A new tool to assign regimen intensity for AML.
    Sorror ML; Agarwal S; Othus M; Lynch Y; Nyland JE; Percival ME; Becker PS; Appelbaum FR; Estey EH
    Cancer Med; 2020 Sep; 9(18):6515-6523. PubMed ID: 32706528
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Real-world treatment patterns and healthcare resource use in patients with acute myeloid leukemia in Western Europe.
    Kabra M; Margotto L; Manuguid F
    Future Oncol; 2021 Jul; 17(21):2769-2784. PubMed ID: 33881356
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.